Shah Gaurav, CEO of Rocket Pharmaceuticals RCKT, has filed 1 purchase and 16 sales on the open market. Over the past 12 months that comes to a net sale of $268.5K. The latest trade was on 05/21.

Shah Gaurav

CEO

Company: Rocket Pharmaceuticals RCKT
First filing: 23/02/22

Trades: 50 trades
Buys / sales: 1 / 16
12-month net buying: −$268.5K
Last trade: 05/21

Trading activity

Transactions

	Trade type
Rocket PharmaceuticalsRCKT	Open-market sale	05/21	05/26	55,684 sh	$3.09	$172,063.56	−5.0%
Rocket PharmaceuticalsRCKT	Open-market sale	05/19	05/21	2,409 sh	$3.01	$7,251.09	−0.2%
Rocket PharmaceuticalsRCKT	Open-market sale	05/13	05/14	2,728 sh	$3.61	$9,848.08	−0.3%
Rocket PharmaceuticalsRCKT	Open-market sale	02/18	02/20	5,990 sh	$3.34	$20,006.6	−0.6%
Rocket PharmaceuticalsRCKT	Open-market sale	02/13	02/18	12,279 sh	$3.31	$40,643.49	−1.2%
Rocket PharmaceuticalsRCKT	Open-market sale	25/11/18	25/11/20	6,276 sh	$2.98	$18,702.48	−0.8%
Rocket PharmaceuticalsRCKT	Open-market sale	25/05/20	25/05/22	2,253 sh	$6.45	$14,531.85	−0.3%
Rocket PharmaceuticalsRCKT	Open-market sale	25/05/16	25/05/20	3,621 sh	$6.53	$23,645.13	−0.5%
Rocket PharmaceuticalsRCKT	Open-market buy	25/04/10	25/04/14	20,000 sh	$5.08	$101,600	+2.6%
Rocket PharmaceuticalsRCKT	Open-market sale	25/02/21	25/02/25	16,303 sh	$10.58	$172,485.74	−2.1%
Rocket PharmaceuticalsRCKT	Open-market sale	24/11/21	24/11/25	11,091 sh	$13.05	$144,737.55	−1.5%
Rocket PharmaceuticalsRCKT	Open-market sale	24/08/16	24/08/20	9,650 sh	$18.50	$178,525	−1.3%
Rocket PharmaceuticalsRCKT	Open-market sale	24/05/16	24/05/20	9,790 sh	$23.35	$228,596.5	−1.3%
Rocket PharmaceuticalsRCKT	Open-market sale	24/02/16	24/02/21	20,272 sh	$29.84	$604,916.48	−3.5%
Rocket PharmaceuticalsRCKT	Open-market sale	23/08/17	23/08/21	4,767 sh	$15.47	$73,745.49	−0.9%
Rocket PharmaceuticalsRCKT	Open-market sale	23/05/17	23/05/19	4,122 sh	$21.38	$88,128.36	−0.8%
Rocket PharmaceuticalsRCKT	Open-market sale	23/02/17	23/02/22	12,194 sh	$19.06	$232,417.64	−2.2%